Clonality of neutrophilia associated with plasma cell neoplasms: Report of a SETBP1 mutation and analysis of a single institution series

Brett Stevens, Julia Maxson, Jeffrey Tyner, Clayton A. Smith, Jonathan A. Gutman, William Robinson, Craig T. Jordan, Choon Kee Lee, Karen Swisshelm, Jennifer Tobin, Qi Wei, Jeffrey Schowinsky, Sean Rinella, Hea Gie Lee, Daniel A. Pollyea

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A rare but well-known association between plasma cell neoplasms and neutrophilia is known to exist. Whether the neutrophilia is secondary to the plasma cell neoplasm or this convergence represents two independent clonal disorders is unclear. We reviewed five consecutive cases from a single institution over a 3-year period, applying molecular, cytogenetic and cytokine-profiling approaches to determine whether neutrophilia associated with plasma cell neoplasms represents a reactive or clonal process. We report, for the first time, the occurrence of a SETBP1 mutation in two cases, as well as changes in G-CSF and IL-6 in SETBP1 wild type vs. mutated patients that are supportive of a hypothesis that neutrophilia associated with plasma cell neoplasms may sometimes be reactive and may sometimes represent a second clonal entity. Finally, using an ex vivo drug screening platform we report the potential efficacy of the multi-kinase inhibitor dasatinib in select patients.

Original languageEnglish (US)
Pages (from-to)927-934
Number of pages8
JournalLeukemia and Lymphoma
Volume57
Issue number4
DOIs
StatePublished - Apr 2 2016

Fingerprint

Plasma Cell Neoplasms
Mutation
Preclinical Drug Evaluations
Granulocyte Colony-Stimulating Factor
Cytogenetics
Interleukin-6
Phosphotransferases
Cytokines

Keywords

  • Chronic neutrophilic leukemia
  • neutrophilia
  • plasma cell neoplasm
  • SETBP1

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Clonality of neutrophilia associated with plasma cell neoplasms : Report of a SETBP1 mutation and analysis of a single institution series. / Stevens, Brett; Maxson, Julia; Tyner, Jeffrey; Smith, Clayton A.; Gutman, Jonathan A.; Robinson, William; Jordan, Craig T.; Lee, Choon Kee; Swisshelm, Karen; Tobin, Jennifer; Wei, Qi; Schowinsky, Jeffrey; Rinella, Sean; Lee, Hea Gie; Pollyea, Daniel A.

In: Leukemia and Lymphoma, Vol. 57, No. 4, 02.04.2016, p. 927-934.

Research output: Contribution to journalArticle

Stevens, B, Maxson, J, Tyner, J, Smith, CA, Gutman, JA, Robinson, W, Jordan, CT, Lee, CK, Swisshelm, K, Tobin, J, Wei, Q, Schowinsky, J, Rinella, S, Lee, HG & Pollyea, DA 2016, 'Clonality of neutrophilia associated with plasma cell neoplasms: Report of a SETBP1 mutation and analysis of a single institution series', Leukemia and Lymphoma, vol. 57, no. 4, pp. 927-934. https://doi.org/10.3109/10428194.2015.1094697
Stevens, Brett ; Maxson, Julia ; Tyner, Jeffrey ; Smith, Clayton A. ; Gutman, Jonathan A. ; Robinson, William ; Jordan, Craig T. ; Lee, Choon Kee ; Swisshelm, Karen ; Tobin, Jennifer ; Wei, Qi ; Schowinsky, Jeffrey ; Rinella, Sean ; Lee, Hea Gie ; Pollyea, Daniel A. / Clonality of neutrophilia associated with plasma cell neoplasms : Report of a SETBP1 mutation and analysis of a single institution series. In: Leukemia and Lymphoma. 2016 ; Vol. 57, No. 4. pp. 927-934.
@article{872d3120582a406ca682bcb30e6e9ea7,
title = "Clonality of neutrophilia associated with plasma cell neoplasms: Report of a SETBP1 mutation and analysis of a single institution series",
abstract = "A rare but well-known association between plasma cell neoplasms and neutrophilia is known to exist. Whether the neutrophilia is secondary to the plasma cell neoplasm or this convergence represents two independent clonal disorders is unclear. We reviewed five consecutive cases from a single institution over a 3-year period, applying molecular, cytogenetic and cytokine-profiling approaches to determine whether neutrophilia associated with plasma cell neoplasms represents a reactive or clonal process. We report, for the first time, the occurrence of a SETBP1 mutation in two cases, as well as changes in G-CSF and IL-6 in SETBP1 wild type vs. mutated patients that are supportive of a hypothesis that neutrophilia associated with plasma cell neoplasms may sometimes be reactive and may sometimes represent a second clonal entity. Finally, using an ex vivo drug screening platform we report the potential efficacy of the multi-kinase inhibitor dasatinib in select patients.",
keywords = "Chronic neutrophilic leukemia, neutrophilia, plasma cell neoplasm, SETBP1",
author = "Brett Stevens and Julia Maxson and Jeffrey Tyner and Smith, {Clayton A.} and Gutman, {Jonathan A.} and William Robinson and Jordan, {Craig T.} and Lee, {Choon Kee} and Karen Swisshelm and Jennifer Tobin and Qi Wei and Jeffrey Schowinsky and Sean Rinella and Lee, {Hea Gie} and Pollyea, {Daniel A.}",
year = "2016",
month = "4",
day = "2",
doi = "10.3109/10428194.2015.1094697",
language = "English (US)",
volume = "57",
pages = "927--934",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Clonality of neutrophilia associated with plasma cell neoplasms

T2 - Report of a SETBP1 mutation and analysis of a single institution series

AU - Stevens, Brett

AU - Maxson, Julia

AU - Tyner, Jeffrey

AU - Smith, Clayton A.

AU - Gutman, Jonathan A.

AU - Robinson, William

AU - Jordan, Craig T.

AU - Lee, Choon Kee

AU - Swisshelm, Karen

AU - Tobin, Jennifer

AU - Wei, Qi

AU - Schowinsky, Jeffrey

AU - Rinella, Sean

AU - Lee, Hea Gie

AU - Pollyea, Daniel A.

PY - 2016/4/2

Y1 - 2016/4/2

N2 - A rare but well-known association between plasma cell neoplasms and neutrophilia is known to exist. Whether the neutrophilia is secondary to the plasma cell neoplasm or this convergence represents two independent clonal disorders is unclear. We reviewed five consecutive cases from a single institution over a 3-year period, applying molecular, cytogenetic and cytokine-profiling approaches to determine whether neutrophilia associated with plasma cell neoplasms represents a reactive or clonal process. We report, for the first time, the occurrence of a SETBP1 mutation in two cases, as well as changes in G-CSF and IL-6 in SETBP1 wild type vs. mutated patients that are supportive of a hypothesis that neutrophilia associated with plasma cell neoplasms may sometimes be reactive and may sometimes represent a second clonal entity. Finally, using an ex vivo drug screening platform we report the potential efficacy of the multi-kinase inhibitor dasatinib in select patients.

AB - A rare but well-known association between plasma cell neoplasms and neutrophilia is known to exist. Whether the neutrophilia is secondary to the plasma cell neoplasm or this convergence represents two independent clonal disorders is unclear. We reviewed five consecutive cases from a single institution over a 3-year period, applying molecular, cytogenetic and cytokine-profiling approaches to determine whether neutrophilia associated with plasma cell neoplasms represents a reactive or clonal process. We report, for the first time, the occurrence of a SETBP1 mutation in two cases, as well as changes in G-CSF and IL-6 in SETBP1 wild type vs. mutated patients that are supportive of a hypothesis that neutrophilia associated with plasma cell neoplasms may sometimes be reactive and may sometimes represent a second clonal entity. Finally, using an ex vivo drug screening platform we report the potential efficacy of the multi-kinase inhibitor dasatinib in select patients.

KW - Chronic neutrophilic leukemia

KW - neutrophilia

KW - plasma cell neoplasm

KW - SETBP1

UR - http://www.scopus.com/inward/record.url?scp=84961057702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961057702&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1094697

DO - 10.3109/10428194.2015.1094697

M3 - Article

C2 - 26389776

AN - SCOPUS:84961057702

VL - 57

SP - 927

EP - 934

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 4

ER -